Background <p>High-intensity interval training (HIIT) is an effective strategy to improve age-related cardiometabolic risk. Coenzyme Q10 (CoQ10), a mitochondrial cofactor and antioxidant, may potentiate exercise-induced metabolic adaptations<b>.</b></p> Aim <p>This study examined whether combining CoQ10 with HIIT provides additional metabolic benefits in older adults.</p> Methods <p>Thirty-eight healthy older adults (65–75 years) were randomly assigned to HIIT + CoQ10 (<i>n</i> = 19) or HIIT + placebo (<i>n</i> = 19) for 8 weeks (three sessions per week). Participants received 100 mg/day of CoQ10 or placebo. Fasting glucose (FBG), insulin, homeostatic model assessment of insulin resistance (HOMA-IR), lipid profile including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein (vLDL), and liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured before and after the intervention.</p> Results <p>Both groups demonstrated significant improvements in glycemic indices, lipid profile, and liver enzymes over time (<i>p</i> &lt; 0.05). Significant time × group interactions were observed for insulin, HOMA-IR, TC, TG, LDL-C, and vLDL, indicating greater improvements with HIIT + CoQ10. No additive effect of CoQ10 was observed for ALT or AST.</p> Discussion <p>Eight weeks of HIIT improved cardiometabolic health in older adults. Both HIIT + CoQ10 and HIIT + placebo groups showed improvements in glycemic indices and lipid profile, but CoQ10 further enhanced insulin sensitivity and lipid metabolism, suggesting that it may potentiate exercise-induced metabolic adaptations.</p> Conclusion <p>HIIT improves cardiometabolic health in older adults, with CoQ10 further enhancing insulin sensitivity and lipid metabolism.</p> Trial registration <p>IRCT20240310061243N1. Registered 10 March 2024 (retrospectively registered).</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Impact of CoQ10 supplementation on metabolic adaptations to HIIT in older adults: focus on glycemic control, insulin resistance, lipid profile, and liver enzyme

  • Navid Bagheri,
  • Mehdi Kargarfard

摘要

Background

High-intensity interval training (HIIT) is an effective strategy to improve age-related cardiometabolic risk. Coenzyme Q10 (CoQ10), a mitochondrial cofactor and antioxidant, may potentiate exercise-induced metabolic adaptations.

Aim

This study examined whether combining CoQ10 with HIIT provides additional metabolic benefits in older adults.

Methods

Thirty-eight healthy older adults (65–75 years) were randomly assigned to HIIT + CoQ10 (n = 19) or HIIT + placebo (n = 19) for 8 weeks (three sessions per week). Participants received 100 mg/day of CoQ10 or placebo. Fasting glucose (FBG), insulin, homeostatic model assessment of insulin resistance (HOMA-IR), lipid profile including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein (vLDL), and liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured before and after the intervention.

Results

Both groups demonstrated significant improvements in glycemic indices, lipid profile, and liver enzymes over time (p < 0.05). Significant time × group interactions were observed for insulin, HOMA-IR, TC, TG, LDL-C, and vLDL, indicating greater improvements with HIIT + CoQ10. No additive effect of CoQ10 was observed for ALT or AST.

Discussion

Eight weeks of HIIT improved cardiometabolic health in older adults. Both HIIT + CoQ10 and HIIT + placebo groups showed improvements in glycemic indices and lipid profile, but CoQ10 further enhanced insulin sensitivity and lipid metabolism, suggesting that it may potentiate exercise-induced metabolic adaptations.

Conclusion

HIIT improves cardiometabolic health in older adults, with CoQ10 further enhancing insulin sensitivity and lipid metabolism.

Trial registration

IRCT20240310061243N1. Registered 10 March 2024 (retrospectively registered).